Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alli Message Challenges Cultural Bias, Mistrust Of Health Care Services

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline's marketing of the OTC weight-loss product alli is successful if it prompts overweight African-American and Hispanic consumers to consider what weight loss actually requires, according to Dr. Valentine J. Burroughs, chairman of the National Medical Association's Health Policy Committee

You may also be interested in...



GSK Offers Weight Loss Hotline, Web Site To Help “Make This Year Different”

GlaxoSmithKline offered a program, sponsored by its alli OTC weight-loss drug, during the first week of this year to educate consumers about proven weight-loss strategies and to warn about ineffective products

GSK Offers Weight Loss Hotline, Web Site To Help “Make This Year Different”

GlaxoSmithKline offered a program, sponsored by its alli OTC weight-loss drug, during the first week of this year to educate consumers about proven weight-loss strategies and to warn about ineffective products

GSK Offers Weight Loss Hotline, Web Site To Help “Make This Year Different”

GlaxoSmithKline offered a program, sponsored by its alli OTC weight-loss drug, during the first week of this year to educate consumers about proven weight-loss strategies and to warn about ineffective products

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101101

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel